Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation
View abstract on PubMed
Summary
This summary is machine-generated.Autosomal-dominant Alzheimer's disease (ADAD) linked to the PSEN1 E280A mutation shows early cognitive decline. Verbal, semantic, episodic, and spatial memory tests are key indicators for detecting preclinical changes in carriers.
Area Of Science
- Neuroscience
- Genetics
- Psychology
Background
- The largest kindred with autosomal-dominant Alzheimer's disease (ADAD) worldwide carries the PSEN1 E280A mutation in Colombia.
- Mutation carriers typically develop dementia starting in their late 30s, with a median onset age of 49, and cognitive decline is a primary symptom.
Purpose Of The Study
- To synthesize existing literature on neuropsychological assessments in PSEN1 E280A mutation carriers across their lifespan.
- To provide a comprehensive overview of cognitive outcomes in this unique ADAD population.
Main Methods
- A systematic review and integration of published research on neuropsychological assessments in PSEN1 E280A carriers.
- Analysis focused on memory domains (verbal, semantic, episodic, spatial) and other cognitive functions (language, attention, visuospatial, executive functioning).
Main Results
- Verbal, semantic, episodic, and spatial memory tests are the most sensitive indicators of preclinical changes in PSEN1 E280A carriers.
- Inconsistent findings were observed for language, attention, visuospatial memory, and executive functioning tests, indicating potential limitations in early detection.
- Specialized cognitive tasks for this population are effective but underutilized.
Conclusions
- Continued development of cognitive tests is crucial for early ADAD detection and screening in PSEN1 E280A carriers.
- Investigating ADAD mutations in children could reveal early Alzheimer's disease changes and improve understanding of lifespan neuropsychological functioning.
- This synthesis offers valuable insights for ADAD research, clinical management, and policy development.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Overview
An organism is diploid if it inherits two variants, or alleles, of each gene, one from each parent. These two alleles constitute the genotype for a given gene. The term genotype is also used to refer to an organism’s complete set of genes. A diploid organism with two identical alleles has a homozygous genotype, whereas two different alleles indicates a heterozygous genotype. Observable traits arising from genotypes are called phenotypes, which can also be influenced by...

